Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02851147 · ClinicalTrials.gov registry record
Slit Lamp Model SL-D-301 and DC-4 Digital Camera Attachment
A clinical trial of Ocular Images, sponsored by Topcon Medical Systems.
- Completed
- Registry status
- 30
- Enrollment target
- 1
- Study location
NCT02851147: Completed study of Ocular Images, sponsored by Topcon Medical Systems.
NCT02851147 is a study of Ocular Images that has completed, run by Topcon Medical Systems. The registered enrollment target is 30 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02851147, a study of Ocular Images, has completed, sponsored by Topcon Medical Systems.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the evaluation is to confirm operability and usability of the SL-D301 Slit Lamp and the DC-4 digital camera attachment by conducting a usability evaluation and subsequently submitting a questionnaire and hold an interview with the operator. Of special interest for the study is to confirm whether the illumination level of SL-D301 is enough to perform an eye exam since the maximum illumination level on the SL-D301 is lower than other existing Topcon digital ready slit lamps due to regulations that limit the maximum light intensity on the human eye. The SL-D301 will be compared against the predicate device SL-3G.
Conditions Studied
Interventions
- DEVICE SL-D301
- DEVICE DC-4
- DEVICE SL-3G
Study Locations (1)
New Jersey
- Glassman Eye Associates - Teaneck
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2016-05 |
| Est. Completion | 2016-06 |
What the finished NCT02851147 record still lists
NCT02851147 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 1 condition, with Ocular Images appearing as the primary indexed condition, and to 3 interventions - of which SL-D301 is the first listed.
NCT02851147 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT02851147 about?
NCT02851147 is a clinical study titled "Slit Lamp Model SL-D-301 and DC-4 Digital Camera Attachment". The purpose of the evaluation is to confirm operability and usability of the SL-D301 Slit Lamp and the DC-4 digital camera attachment by conducting a usability evaluation and subsequently submitting a questionnaire and hold an interview with the operator. Of special interest for the study is to con...
What is the current status of trial NCT02851147?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2016-05. Estimated completion is 2016-06.
What conditions does trial NCT02851147 study?
This clinical trial studies the following conditions: Ocular Images.
What interventions are being tested in trial NCT02851147?
The interventions under investigation include: SL-D301 (DEVICE), DC-4 (DEVICE), SL-3G (DEVICE).
Who is sponsoring clinical trial NCT02851147?
This trial is sponsored by Topcon Medical Systems, which has 24 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02851147 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia